Further investigations revealed that the inhibitory Ser9 phosphorylation of GSK3β was largely absent in colon cancer cell lines, whereas the activating Tyr216 phosphorylation remains, suggesting deregulated GSK3β function. Here, GSK3B is linked to malignant colon neoplasm.